Due to health issues, this site is no longer maintained and will be shut down shortly.

RGBP Regen Biopharma Inc

Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It intends to develop small molecule NR2F6 that activates to immune cell for oncology and autoimmune diseases. The company was incorporated in 2012 and is based in La Mesa, California.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$1.90    Pink
As of 03/23/2023     OTCMarkets

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  11/30/2018
Outstanding shares:  5,048,430,270
Average volume:  11,240,794
Market cap:   $9,592,018
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy